Phase Ib: Preliminary clinical activity and immune activation for NKTR-262 [TLR 7/8 agonist] plus NKTR-214 [CD122-biased agonist] in patients (pts) with locally advanced or metastatic solid tumors (REVEAL Phase Ib/II Trial) Meeting Abstract
| Authors: | Diab, A.; Marcondes, M.; Kotzin, B.; Tagliaferri, M. A.; Hoch, U.; Li, Y.; Cattaruzza, F.; Zalevsky, J.; Brohl, A. S.; Brugarolas, J.; Bilen, M. A.; Gupta, S.; Musibay, E. D.; Conley, A. P.; Borazanci, E. H.; D'Angelo, S. P.; Curti, B. D. |
| Abstract Title: | Phase Ib: Preliminary clinical activity and immune activation for NKTR-262 [TLR 7/8 agonist] plus NKTR-214 [CD122-biased agonist] in patients (pts) with locally advanced or metastatic solid tumors (REVEAL Phase Ib/II Trial) |
| Meeting Title: | 2019 ASCO-SITC Clinical Immuno-Oncology Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 8 Suppl. |
| Meeting Dates: | 2019 Feb 28-Mar 2 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-03-10 |
| Language: | English |
| ACCESSION: | WOS:000489109600039 |
| DOI: | 10.1200/JCO.2019.37.8_suppl.26 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 26 -- Source: Wos |
